home / stock / bway / bway news

BWAY News and Press, BrainsWay Ltd. From 01/11/23

Stock Information
Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com
Menu
BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...
BWAY - BrainsWay Announces Extended Private Insurance Coverage in Washington State for the Treatment of OCD and Depression Utilizing Deep TMS(TM)

BURLINGTON, Mass. and JERUSALEM, Jan. 11, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that a major pri...
BWAY - BrainsWay resolves unfair competition litigation with Neuronetics

BrainsWay ( NASDAQ: BWAY ), a developer of non-invasive treatments for brain disorders, has settled an unfair competition litigation with medical technology company Neuronetics ( NASDAQ: STIM ). The litigation had been filed by STIM in the district of Delaware against BrainsWa...

BWAY - BrainsWay Resolves Neuronetics Litigation

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported that it has settled litigation filed by...

BWAY - BrainsWay Reports Open Market Stock Purchase by Board Member Yossi Ben Shalom

BURLINGTON, Mass. and JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported a recent open market purchase of Brains...
BWAY - BrainsWay Reports Open Market Stock Purchases by Two Board Members

BURLINGTON, Mass. and JERUSALEM, Nov. 28, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported that David Zacut, M.D., BrainsWay...

BWAY - BrainsWay Ltd. (BWAY) Q3 2022 Results - Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q3 2022 Results Earnings Conference Call November 16, 2022, 08:30 AM ET Company Participants Bob Yedid - Investor Relations, LifeSci Advisors Christopher von Jako - President and Chief Executive Officer Scott Areglado - Chief Financial Offic...

BWAY - BrainsWay stock plummets 29% as Q3 loss widens, revenue falls

BrainsWay ( NASDAQ: BWAY ) stock fell ~29% on Wednesday after Q3 results missed estimates. Net loss and total comprehensive loss widened to -$5.04M, compared to -$1.80M in Q3 2021. Revenue declined -35.89% Y/Y to $5.17M. "While the current macroeco...
BWAY - Brainsway GAAP EPS of -$0.15 misses by $0.09, revenue of $5.17M misses by $3.28M

Brainsway press release ( NASDAQ: BWAY ): Q3 GAAP EPS of -$0.15 misses by $0.09 . Revenue of $5.17M (-35.9% Y/Y) misses by $3.28M . As of September 30, 2022, BrainsWay’s Deep TMS™ installed base was 851 total systems, a 19% increase from the insta...

BWAY - BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights

BURLINGTON, Mass. and JERUSALEM, Nov. 16, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported third quarter 2022 financial resu...

BWAY - BrainsWay Announces Private Insurance Coverage from Premera Blue Cross for the Treatment of OCD Utilizing Deep TMS(TM)

BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Preme...
Previous 10 Next 10